Deucravacitinib
bms
['bms', 'scienceatbms']
explore our 2-year results from our phase 3 program in plaque #psoraisis in our #eadvcongress e-poster.
Official Bristol Myers Squibb Twitter handle for science. Connecting researchers, scientists and healthcare professionals through science; guidelines below: